Dopamine responsiveness is regulated by targeted sorting of D2 receptors

Proceedings of the National Academy of Sciences of the United States of America

Volumn 102, Issue 32, 2005, Pages 11521-11526

  Bartlett, Selena E ^a   Enquist, Johan ^a,c   Hopf, Frederic W ^a   Lee, Josephine H ^a   Gladher, Fredrik ^a   Kharazia, Viktor ^a   Waldhoer, Maria ^a   Mailliard, William S ^a   Armstrong, Randall ^a   Bonci, Antonello ^a,b   Whistler, Jennifer L ^a,c  

^a UNIVERSITY OF CALIFORNIA SAN FRANCISCO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c LUND UNIVERSITY   (Sweden)

Author keywords

Degradation; Down regulation; G protein coupled receptor; Resensitization; Trafficking

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; BACLOFEN; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; G PROTEIN COUPLED RECEPTOR; HALOPERIDOL; QUINPIROLE; RACLOPRIDE;

ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CELL STRAIN HEK293; DOPAMINERGIC SYSTEM; EMBRYO; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION;

ANIMALS; BRAIN; CELL LINE; DOPAMINE; DOWN-REGULATION; ELECTROPHYSIOLOGY; GLUTATHIONE TRANSFERASE; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; VESICULAR TRANSPORT PROTEINS;

EID: 23844437253     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0502418102     Document Type: Article

References (21)

1. Bohm, S. K., Grady, E. F. & Bunnett, N. W. (1997) Biochem. J. 322, 1-18.
2. Tsao, P. I. & von Zastrow, M. (2000) J. Biol. Chem. 275, 11130-11140.
3. Whistler, J. L., Enquist, J., Marley, A., Fong, J., Gladher, F., Tsuruda, P., Murray, S. R. & von Zastrow, M. (2002) Science 297, 615-620.
4. Ariano, M. A., Sortwell, C. E., Ray, M., Altemus, K. L., Sibley, D. R. & Levine, M. S. (1997) Synapse 27, 313-321.
5. Volkow, N. D., Fowler, J. S. & Wang, G. J. (1999) J. Psychopharmacol. 13, 337-345.
6. Dumartin, B., Jaber, M., Gonon, F., Caron, M. G., Giros, B. & Bloch, B. (2000) Proc. Natl. Acad. Sci. USA 97, 1879-1884.
7. Jones, S. R., Gainetdinov, R. R., Hu, X. T., Cooper, D. C., Wightman, R. M., White, F. J. & Caron, M. G. (1999) Nat. Neurosci. 2, 649-655.
8. Jeziorski, M. & White, F. J. (1989) Synapse 4, 267-280.
9. Margolis, E. B., Hjelmstad, G. O., Bonci, A. & Fields, H. L. (2003) J. Neurosci. 23, 9981-9986.
10. Hopf, F. W., Cascini, M. G., Gordon, A. S., Diamond, I. & Bonci, A. (2003) J. Neurosci. 23, 5079-5087.
11. Vickery, R. G. & von Zastrow, M. (1999) J. Cell Biol. 144, 31-43.
12. Finn, A. K. & Whistler, J. L. (2001) Neuron 32, 829-839.
13. Hunter, S. A., Burstein, S. & Renzulli, L. (1986) Neurochem. Res. 11, 1273-1288.
14. Kharazia, V. N., Jacobs, K. M. & Prince, D. A. (2003) Neuroscience 120, 207-218.
15. Wojcikiewicz, R. J. (2004) Trends Pharmacol. Sci. 25, 35-41.
16. Hislop, J. N., Marley, A. & von Zastrow, M. (2004) J. Biol. Chem. 279, 22522-22531.
17. Bonci, A., Bernardi, G., Grillner, P. & Mercuri, N. B. (2003) Trends Pharmacol. Sci. 24, 172-177.
18. Cruz, H. G., Ivanova, T., Lunn, M. L., Stoffel, M., Slesinger, P. A. & Luscher, C. (2004) Nat. Neurosci. 7, 153-159.
19. Pillai, G., Brown, N. A., McAllister, G., Milligan, G. & Seabrook, G. R. (1998) Neuropharmacology 37, 983-987.
20. Alvarez, V. A., Arttamangkul, S., Dang, V., Salem, A., Whistler, J. L., Von Zastrow, M., Grandy, D. K. & Williams, J. T. (2002) J. Neurosci. 22, 5769-5776.
21. Avissar, S., Barki-Harrington, L., Nechamkin, Y., Roitman, G. & Schreiber, G. (2001) Schizophr. Res. 47, 37-47.